These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23360883)

  • 41. Two faces of microbiota in inflammatory and autoimmune diseases: triggers and drugs.
    Kverka M; Tlaskalova-Hogenova H
    APMIS; 2013 May; 121(5):403-21. PubMed ID: 23094605
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Inflammatory bowel disease: genetic or environmental diseases?].
    Cortot A; Pineton de Chambrun G; Vernier-Massouille G; Vigneron B; Gower Rousseau C
    Gastroenterol Clin Biol; 2009; 33(8-9):681-91. PubMed ID: 19716246
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening detects a high proportion of celiac disease in young HLA-genotyped children.
    Björck S; Brundin C; Lörinc E; Lynch KF; Agardh D
    J Pediatr Gastroenterol Nutr; 2010 Jan; 50(1):49-53. PubMed ID: 19915493
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microbiota regulation of inflammatory bowel disease and colorectal cancer.
    Liu Z; Cao AT; Cong Y
    Semin Cancer Biol; 2013 Dec; 23(6 Pt B):543-52. PubMed ID: 24071482
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dysbiosis a risk factor for celiac disease.
    Girbovan A; Sur G; Samasca G; Lupan I
    Med Microbiol Immunol; 2017 Apr; 206(2):83-91. PubMed ID: 28204873
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic background of celiac disease and its clinical implications.
    Wolters VM; Wijmenga C
    Am J Gastroenterol; 2008 Jan; 103(1):190-5. PubMed ID: 18184122
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drosophila as a model for intestinal dysbiosis and chronic inflammatory diseases.
    Lee KA; Lee WJ
    Dev Comp Immunol; 2014 Jan; 42(1):102-10. PubMed ID: 23685204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Etiology and pathogenesis of inflammatory bowel disease.
    Schmidt C; Stallmach A
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):127-45. PubMed ID: 15990703
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mannose-binding lectin level and deficiency is not associated with inflammatory bowel diseases, disease phenotype, serology profile, and NOD2/CARD15 genotype in a large Hungarian cohort.
    Papp M; Lakatos PL; Harsfalvi J; Farkas G; Palatka K; Udvardy M; Molnar T; Farkas K; Nagy F; Veres G; Lakatos L; Kovacs A; Dinya T; Kocsis AK; Papp J; ; Altorjay I
    Hum Immunol; 2010 Apr; 71(4):407-13. PubMed ID: 20079790
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The multifaceted role of commensal microbiota in homeostasis and gastrointestinal diseases.
    Silva MJ; Carneiro MB; dos Anjos Pultz B; Pereira Silva D; Lopes ME; dos Santos LM
    J Immunol Res; 2015; 2015():321241. PubMed ID: 25759839
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phenotypic variance in childhood coeliac disease and the HLA-DQ/DR dose effect.
    Vermeulen BA; Hogen Esch CE; Yuksel Z; Koning F; Verduijn W; Doxiadis II; Schreuder GM; Mearin ML
    Scand J Gastroenterol; 2009; 44(1):40-5. PubMed ID: 18932050
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The c.1-260C>T promoter variant of CD14 but not the c.896A>G (p.D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel disease.
    Baumgart DC; Buning C; Geerdts L; Schmidt HH; Genschel J; Fiedler T; Gentz E; Molnar T; Nagy F; Lonovics J; Lochs H; Wiedenmann B; Nickel R; Witt H; Dignass A
    Digestion; 2007; 76(3-4):196-202. PubMed ID: 18174680
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Inflammatory bowel disease: IBD].
    Endo K; Shiga H; Kinouchi Y; Shimosegawa T
    Rinsho Byori; 2009 Jun; 57(6):527-32. PubMed ID: 19621784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multi-omics analysis of inflammatory bowel disease.
    Huang H; Vangay P; McKinlay CE; Knights D
    Immunol Lett; 2014 Dec; 162(2 Pt A):62-8. PubMed ID: 25131220
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease.
    Chu H; Khosravi A; Kusumawardhani IP; Kwon AH; Vasconcelos AC; Cunha LD; Mayer AE; Shen Y; Wu WL; Kambal A; Targan SR; Xavier RJ; Ernst PB; Green DR; McGovern DP; Virgin HW; Mazmanian SK
    Science; 2016 May; 352(6289):1116-20. PubMed ID: 27230380
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microbiota and innate immunity in intestinal inflammation and neoplasia.
    Cario E
    Curr Opin Gastroenterol; 2013 Jan; 29(1):85-91. PubMed ID: 23207600
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunogenetic control of the intestinal microbiota.
    Marietta E; Rishi A; Taneja V
    Immunology; 2015 Jul; 145(3):313-22. PubMed ID: 25913295
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Interaction among Microbiota, Immunity, and Genetic and Dietary Factors Is the Condicio Sine Qua Non Celiac Disease Can Develop.
    Pagliari D; Urgesi R; Frosali S; Riccioni ME; Newton EE; Landolfi R; Pandolfi F; Cianci R
    J Immunol Res; 2015; 2015():123653. PubMed ID: 26090475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The mucosal firewalls against commensal intestinal microbes.
    Macpherson AJ; Slack E; Geuking MB; McCoy KD
    Semin Immunopathol; 2009 Jul; 31(2):145-9. PubMed ID: 19707762
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Touch of Youth in Gut Microbiota Development.
    Magri G; Cerutti A
    Immunity; 2016 Jul; 45(1):12-4. PubMed ID: 27438763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.